These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 18331150)

  • 41. Statistical methods for cost-effectiveness analyses that use data from cluster randomized trials: a systematic review and checklist for critical appraisal.
    Gomes M; Grieve R; Nixon R; Edmunds WJ
    Med Decis Making; 2012; 32(1):209-20. PubMed ID: 21610256
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Accounting for correlation and compliance in cluster randomized trials.
    Loeys T; Vansteelandt S; Goetghebeur E
    Stat Med; 2001 Dec; 20(24):3753-67. PubMed ID: 11782031
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bounds on the average causal effects in randomized trials with noncompliance by covariate adjustment.
    Shan N; Xu PF
    Biom J; 2016 Nov; 58(6):1311-1318. PubMed ID: 27062639
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Performance of analytical methods for overdispersed counts in cluster randomized trials: sample size, degree of clustering and imbalance.
    Durán Pacheco G; Hattendorf J; Colford JM; Mäusezahl D; Smith T
    Stat Med; 2009 Oct; 28(24):2989-3011. PubMed ID: 19672840
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Estimating the Complier Average Causal Effect in a Meta-Analysis of Randomized Clinical Trials With Binary Outcomes Accounting for Noncompliance: A Generalized Linear Latent and Mixed Model Approach.
    Zhou T; Zhou J; Hodges JS; Lin L; Chen Y; Cole SR; Chu H
    Am J Epidemiol; 2022 Jan; 191(1):220-229. PubMed ID: 34564720
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Switching cluster membership in cluster randomized control trials: Implications for design and analysis.
    Schweig JD; Pane JF; McCaffrey DF
    Psychol Methods; 2020 Aug; 25(4):516-534. PubMed ID: 32271041
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Five interval estimators of the risk difference under stratified randomized clinical trials with noncompliance and repeated measurements.
    Lui KJ; Chang KC
    J Biopharm Stat; 2013; 23(4):756-73. PubMed ID: 23786643
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Discussion of "Identifiability and estimation of causal effects in randomized trials with noncompliance and completely nonignorable missing data".
    Small DS; Cheng J
    Biometrics; 2009 Sep; 65(3):682-6; discussion 689-91. PubMed ID: 18759846
    [No Abstract]   [Full Text] [Related]  

  • 49. Beyond intent to treat (ITT): A complier average causal effect (CACE) estimation primer.
    Peugh JL; Strotman D; McGrady M; Rausch J; Kashikar-Zuck S
    J Sch Psychol; 2017 Feb; 60():7-24. PubMed ID: 28164801
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Estimating intervention effects of prevention programs: accounting for noncompliance.
    Stuart EA; Perry DF; Le HN; Ialongo NS
    Prev Sci; 2008 Dec; 9(4):288-98. PubMed ID: 18843535
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Noncompliance in lifestyle intervention studies: the instrumental variable method provides insight into the bias.
    Hertogh EM; Schuit AJ; Peeters PH; Monninkhof EM
    J Clin Epidemiol; 2010 Aug; 63(8):900-6. PubMed ID: 20189770
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Survey of consent practices in cluster randomized trials: improvements are needed in ethical conduct and reporting.
    Taljaard M; Chaudhry SH; Brehaut JC; Weijer C; Boruch R; Donner A; Eccles MP; McRae AD; Saginur R; Zwarenstein M; Grimshaw JM
    Clin Trials; 2014 Feb; 11(1):60-9. PubMed ID: 24346609
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Simple efficient bias corrected instrumental variable estimator for randomized trials with noncompliance.
    Chan KC
    Contemp Clin Trials; 2012 Jul; 33(4):786-93. PubMed ID: 22484340
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A comparison of the statistical power of different methods for the analysis of cluster randomization trials with binary outcomes.
    Austin PC
    Stat Med; 2007 Aug; 26(19):3550-65. PubMed ID: 17238238
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Noninferiority trials with nonadherence to the assigned randomized treatment.
    Korn EL; Gray RJ; Freidlin B
    Clin Trials; 2019 Dec; 16(6):673-681. PubMed ID: 31409130
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The use of random effects models to allow for clustering in individually randomized trials.
    Lee KJ; Thompson SG
    Clin Trials; 2005; 2(2):163-73. PubMed ID: 16279138
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Performance of statistical methods for analysing survival data in the presence of non-random compliance.
    Odondi L; McNamee R
    Stat Med; 2010 Dec; 29(29):2994-3003. PubMed ID: 20963732
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sample size considerations for stratified cluster randomization design with binary outcomes and varying cluster size.
    Xu X; Zhu H; Ahn C
    Stat Med; 2019 Aug; 38(18):3395-3404. PubMed ID: 31033011
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparing denominator degrees of freedom approximations for the generalized linear mixed model in analyzing binary outcome in small sample cluster-randomized trials.
    Li P; Redden DT
    BMC Med Res Methodol; 2015 Apr; 15():38. PubMed ID: 25899170
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Imputation strategies for missing continuous outcomes in cluster randomized trials.
    Taljaard M; Donner A; Klar N
    Biom J; 2008 Jun; 50(3):329-45. PubMed ID: 18537126
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.